FREE STANDARD SHIPPING ON ORDERS $250+

Ipamorelin

From $76.80

Shop

Ipamorelin · Research brief

How to Mix CJC-1295 no DAC & Ipamorelin Calculator Guide

48 WORDS

Short answer

Most researchers get the dilution ratios wrong. Not because the math is hard, but because peptide blend vials don't state concentration the way single-compound vials do. A 10mg vial containing 5mg CJC-1295 no DAC and 5mg Ipamorelin requires different reconstitution calculations than two separate 5mg vials mixed together.

Key takeaways

  • A 10mg CJC-1295 no DAC & Ipamorelin blend vial typically contains 5mg of each peptide, not 10mg of each. Verify per-peptide mass on the COA before calculating reconstitution volumes.
  • Reconstituting a 5mg + 5mg blend vial with 2mL bacteriostatic water yields 2,500mcg/mL concentration for both peptides, requiring 4 units on a U-100 syringe to deliver 100mcg of each compound per injection.
  • The formula for syringe units is: (Target dose in mcg ÷ Concentration in mcg/mL) × 100. This converts the dose volume in mL to insulin syringe units.
  • Unequal-ratio blend vials (e.g., 6mg + 4mg) create two different concentrations in one solution, making accurate dual-peptide dosing from a single syringe draw impossible without advanced pipetting equipment.
  • Reconstitution volumes below 1mL increase concentration too much for practical use with standard insulin syringes. Volumes above 3mL require excessively large injection volumes per dose.

Most researchers get the dilution ratios wrong. Not because the math is hard, but because peptide blend vials don't state concentration the way single-compound vials do. A 10mg vial containing 5mg CJC-1295 no DAC and 5mg Ipamorelin requires different reconstitution calculations than two separate 5mg vials mixed together. The dilution volume you choose determines the concentration per unit on your insulin syringe, and getting this wrong means every subsequent dose is inaccurate. Sometimes by a factor of two or more.

Our team works with research facilities running multi-compound peptide protocols daily. The single most common error we see isn't contamination during reconstitution or improper storage. It's dosing math that assumed single-peptide concentration when the vial contains a blend. Here's what you actually need to calculate before you add bacteriostatic water to any CJC-1295 no DAC & Ipamorelin vial.

How do I calculate the correct dosing after reconstituting a CJC-1295 no DAC & Ipamorelin blend vial?

To mix CJC-1295 no DAC & Ipamorelin calculator-style, divide each peptide's mass (in micrograms) by your total reconstitution volume (in milliliters) to get concentration per mL, then multiply by your target dose and divide by that concentration to find syringe units. For a 10mg blend vial (5mg + 5mg) reconstituted with 2mL bacteriostatic water, each peptide is at 2,500mcg/mL. A 100mcg dose of each peptide requires 0.04mL or 4 units on a U-100 insulin syringe.

The real calculation challenge isn't the formula. It's understanding what your vial actually contains before you start. A lyophilised peptide blend vial labeled '10mg total' typically means 5mg of each compound, not 10mg of each. Some suppliers list peptides separately on the label (e.g., 'CJC-1295 no DAC 5mg / Ipamorelin 5mg'), while others state only total mass. If your vial label reads '10mg' without breakdown, contact the supplier for the exact per-peptide mass before reconstituting. Assuming equal distribution when it's actually 7mg/3mg skews every dose by 40%. This article covers the precise reconstitution math for blend vials, the calculator formulas research teams use to eliminate dosing errors, and what preparation mistakes render accurate calculations meaningless because the peptide degraded before you could dose it.

Step 1: Verify Exact Per-Peptide Mass in Your Blend Vial

Before calculating anything, confirm the specific mass of CJC-1295 no DAC and Ipamorelin in your vial. Not the combined total. Peptide blend vials are manufactured in several formats: equal-ratio blends (5mg + 5mg in a 10mg vial), unequal-ratio blends (6mg + 4mg, 7mg + 3mg), and custom-ratio blends specified by the purchaser. The label should state both compounds individually. If it reads only 'CJC-1295 no DAC & Ipamorelin 10mg' without per-peptide breakdown, you cannot proceed accurately.

Contact your supplier and request the Certificate of Analysis (COA) for that specific batch. It will list HPLC-verified purity and exact mass for each peptide. Research-grade peptides from Real Peptides include batch-specific COAs with per-compound mass listed separately, eliminating this ambiguity entirely. Without verified per-peptide mass, any dilution calculation is speculative. We've seen research teams assume 50/50 distribution when the actual ratio was 60/40. The CJC-1295 dose was correct but the Ipamorelin dose was underdosed by 20% across an entire study.

Step 2: Select Reconstitution Volume Based on Target Concentration

Choose your bacteriostatic water volume based on the final concentration you want per milliliter, not on arbitrary 'standard' volumes. Insulin syringes are marked in units (typically U-100, meaning 100 units = 1mL). Smaller reconstitution volumes create higher concentrations, allowing lower injection volumes per dose. Larger volumes create lower concentrations, requiring more syringe units per dose but offering finer dosing precision.

For a 10mg blend vial (5mg CJC-1295 no DAC + 5mg Ipamorelin), reconstituting with 2mL bacteriostatic water yields 2,500mcg/mL of each peptide. A 100mcg dose of each peptide requires 0.04mL (4 units on a U-100 syringe). Reconstituting the same vial with 1mL yields 5,000mcg/mL per peptide. The same 100mcg dose now requires only 0.02mL (2 units). The smaller syringe volume reduces injection site discomfort but increases the risk of measurement error because 1-unit increments represent larger dose changes.

Our experience shows 2mL reconstitution volume works best for blend vials in the 10mg total range. It balances practical injection volumes (3–6 units per dose) with sufficient dilution to minimize pipetting errors during transfer. Reconstituting with volumes below 1mL makes accurate syringe measurement nearly impossible without laboratory micropipettes.

Step 3: Calculate Per-Peptide Concentration After Reconstitution

Use this formula to calculate the concentration of each peptide in your reconstituted solution:

Concentration (mcg/mL) = Peptide mass (mg) × 1,000 / Reconstitution volume (mL)

For a vial containing 5mg CJC-1295 no DAC and 5mg Ipamorelin, reconstituted with 2mL bacteriostatic water:

  • CJC-1295 no DAC concentration = (5mg × 1,000) / 2mL = 2,500mcg/mL
  • Ipamorelin concentration = (5mg × 1,000) / 2mL = 2,500mcg/mL

Both peptides share the same concentration only because they started with equal mass. If your vial contains 6mg CJC-1295 no DAC and 4mg Ipamorelin reconstituted with 2mL:

  • CJC-1295 no DAC = 3,000mcg/mL
  • Ipamorelin = 2,000mcg/mL

You now have two different concentrations in the same vial. To dose 100mcg of each peptide, you'd need different syringe volumes for each compound. Which is impossible from a single mixed vial. This is why verifying equal-ratio blends matters before purchase.

Step 4: Determine Syringe Units Required Per Dose Using the Calculator Formula

Once you know concentration per mL for each peptide, calculate the syringe volume (in units) needed to deliver your target dose:

Syringe units = (Target dose in mcg / Concentration in mcg per mL) × 100

The × 100 converts milliliters to units on a U-100 insulin syringe (100 units = 1mL).

Example: You want 100mcg CJC-1295 no DAC and 100mcg Ipamorelin per injection. Your vial has 2,500mcg/mL of each peptide after 2mL reconstitution.

  • Syringe units = (100mcg / 2,500mcg/mL) × 100 = 4 units

Both peptides require the same syringe volume because they have identical concentrations. If you wanted 200mcg of each peptide instead:

  • Syringe units = (200mcg / 2,500mcg/mL) × 100 = 8 units

For unequal-ratio vials, this formula exposes the dosing problem immediately. If CJC-1295 is at 3,000mcg/mL and Ipamorelin is at 2,000mcg/mL, a 100mcg dose of CJC requires 3.3 units while 100mcg of Ipamorelin requires 5 units. You can't dose both accurately from one syringe draw.

CJC-1295 no DAC & Ipamorelin: Reconstitution Dosing Comparison

Vial Contents Reconstitution Volume CJC-1295 Concentration Ipamorelin Concentration Dose Per 100mcg Each Peptide Syringe Precision
5mg + 5mg (equal blend) 1mL 5,000mcg/mL 5,000mcg/mL 2 units Low. High concentration limits fine-tuning
5mg + 5mg (equal blend) 2mL 2,500mcg/mL 2,500mcg/mL 4 units Optimal. 1-unit changes = 25mcg dose shifts
5mg + 5mg (equal blend) 3mL 1,667mcg/mL 1,667mcg/mL 6 units High. Allows sub-unit dosing adjustments
6mg + 4mg (unequal blend) 2mL 3,000mcg/mL 2,000mcg/mL 3.3 units CJC / 5 units Ipa Not viable. Cannot dose both from one draw
10mg + 10mg (double-strength equal blend) 2mL 5,000mcg/mL 5,000mcg/mL 2 units Low. Requires very small volumes per dose
Professional Assessment 2mL is the practical standard for 5mg + 5mg blends. Balances injection volume, dosing accuracy, and ease of measurement with standard U-100 insulin syringes. Unequal-ratio blends should be avoided unless you're using micropipettes or dosing only one peptide from the vial.

What If: CJC-1295 no DAC & Ipamorelin Reconstitution Scenarios

What If My Vial Label Doesn't Specify Per-Peptide Mass?

Do not reconstitute until you receive the Certificate of Analysis from your supplier. Email or call and request the COA for your specific batch number. It will list HPLC-verified mass for CJC-1295 no DAC and Ipamorelin separately. Assuming equal distribution when the blend is actually 60/40 or 70/30 means every dose is miscalculated. Research-grade suppliers like Real Peptides include batch-specific COAs with every order, eliminating this ambiguity. If your supplier cannot provide a COA, the peptide should not be used for research requiring dosing precision.

What If I Want to Adjust My Dose Mid-Protocol?

Recalculate syringe units using the same formula with your new target dose. If you initially dosed 100mcg of each peptide (4 units from a 2,500mcg/mL solution) and want to increase to 150mcg, the new dose is (150mcg / 2,500mcg/mL) × 100 = 6 units. Each 1-unit change on your syringe represents a 25mcg dose change when concentration is 2,500mcg/mL. This allows fine-tuning in 25mcg increments without reconstituting a new vial. Higher concentrations (e.g., 5,000mcg/mL from 1mL reconstitution) make 1-unit syringe changes equal 50mcg dose shifts, reducing adjustment precision.

What If I Accidentally Reconstituted With More Bacteriostatic Water Than Intended?

Your concentration is now lower than calculated, meaning you need more syringe units per dose to hit your target. Recalculate using the actual volume you added. If you intended 2mL but added 3mL to a 5mg + 5mg vial, concentration drops from 2,500mcg/mL to 1,667mcg/mL. A 100mcg dose now requires (100 / 1,667) × 100 = 6 units instead of 4. The solution remains usable. Just adjust your dosing volume. Do not attempt to 'concentrate' the solution by removing liquid after reconstitution. You'll remove peptide along with the water.

What If My Insulin Syringe Is U-50 Instead of U-100?

U-50 syringes have 50 units per 1mL instead of 100 units per 1mL. Multiply your calculated dose by 0.5 to convert. If your formula shows 4 units on a U-100 syringe, you need 2 units on a U-50 syringe for the same dose volume (0.04mL). Most research settings use U-100 syringes because they're standard in peptide research. U-50 syringes introduce unnecessary conversion complexity and are harder to source.

The Unforgiving Truth About Peptide Blend Reconstitution Calculators

Here's the honest answer: no online calculator can fix bad source data. If you don't know the exact per-peptide mass in your vial, every calculator result is speculative. The formulas themselves are trivial. Divide mass by volume, multiply by target dose. What matters is verifying the input values before you trust the output. We've reviewed hundreds of research protocols where dosing errors traced back to assumed blend ratios rather than verified ones. The vial says '10mg'. The researcher assumes 5mg + 5mg, reconstitutes accordingly, and doses for six weeks before realizing the COA listed 6mg + 4mg.

The calculator isn't the weak point. The assumption is. Every blend vial should ship with a Certificate of Analysis listing HPLC purity and per-peptide mass for that specific batch. If your supplier doesn't provide this automatically, request it before reconstituting. If they can't provide it, the peptide isn't research-grade. Real precision comes from verified inputs, not sophisticated math.

Reconstitution Technique: The Step Most Calculators Ignore

Calculating the right dilution ratio matters only if the reconstitution process doesn't degrade the peptides before you dose them. CJC-1295 no DAC and Ipamorelin are both synthetic peptides sensitive to mechanical shear. Injecting bacteriostatic water directly onto the lyophilised powder with force can denature protein structure at the injection site, creating inactive peptide fragments that your syringe will draw and dose as if they were active.

The correct technique: tilt the vial at a 45-degree angle and direct the bacteriostatic water stream against the inside wall of the vial, not directly onto the peptide powder. Let the liquid run down the wall and dissolve the powder by contact diffusion. Don't inject it as a pressurized stream. After adding all the water, swirl gently. Never shake. Shaking introduces air bubbles and mechanical agitation that fragment peptide chains. Allow the solution to sit at room temperature for 2–3 minutes before drawing your first dose.

Temperature during reconstitution matters more than most protocols acknowledge. Bacteriostatic water stored in a refrigerator (2–8°C) should be brought to room temperature before adding it to the peptide vial. The thermal shock from cold liquid hitting lyophilised powder can cause localized crystallization that reduces solubility. Let the bacteriostatic water vial sit at room temperature for 10–15 minutes before use. Once reconstituted, refrigerate the peptide solution immediately at 2–8°C and use within 28 days. Longer storage periods risk bacterial growth even with bacteriostatic water's antimicrobial additives.

Mixing CJC-1295 no DAC & Ipamorelin with a calculator gives you the math. Reconstituting it correctly gives you stable, bioactive peptides worth dosing. Both steps matter equally. Precision is meaningless if the compound degrades before you inject it. For researchers looking to eliminate preparation variables entirely, pre-mixed blends like our CJC1295 Ipamorelin 5MG 5MG ship with verified per-peptide mass and detailed reconstitution protocols, reducing protocol setup time and eliminating the most common calculation errors we see across research settings.

The calculator is a tool. The technique determines whether the calculated dose actually reaches the subject with full bioactivity intact. Get both right, and your peptide protocol runs on verified concentrations rather than optimistic assumptions.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

First verify the exact mass of each peptide from the Certificate of Analysis — don’t assume equal distribution. Divide each peptide’s mass in micrograms by your reconstitution volume in milliliters to get concentration per mL. Then use the formula: syringe units = (target dose in mcg / concentration in mcg/mL) × 100. For a 5mg + 5mg vial reconstituted with 2mL, concentration is 2,500mcg/mL for each peptide, so a 100mcg dose requires 4 units on a U-100 insulin syringe.
The formula works, but the result exposes a dosing problem. If your vial contains 6mg CJC-1295 no DAC and 4mg Ipamorelin in 2mL, you get 3,000mcg/mL CJC and 2,000mcg/mL Ipamorelin. A 100mcg dose of CJC requires 3.3 units while 100mcg Ipamorelin requires 5 units — you can’t dose both accurately from a single syringe draw. Unequal blends should be avoided unless you’re using micropipettes or dosing only one compound.
Your concentration changes, so your dose per syringe unit changes. If you added 3mL instead of 2mL to a 5mg + 5mg vial, concentration drops from 2,500mcg/mL to 1,667mcg/mL — you now need 6 units instead of 4 to deliver 100mcg. The solution remains usable; just recalculate your syringe volume using the actual reconstitution volume. Don’t try to ‘fix’ it by removing liquid — you’ll remove peptide mass along with the water.
When stored at 2–8°C in bacteriostatic water, reconstituted peptide blends remain stable for approximately 28 days. Beyond this window, bacterial contamination risk increases despite the antimicrobial properties of bacteriostatic water, and peptide degradation accelerates. Always refrigerate immediately after reconstitution and never leave the vial at room temperature for more than 30 minutes during dosing.
Poor labeling practices, not manufacturing standards. Research-grade peptide suppliers provide batch-specific Certificates of Analysis with HPLC-verified mass for each compound separately. If your vial label shows only ’10mg total’ without per-peptide specification, contact the supplier for the COA before reconstituting — assuming 50/50 distribution when the actual ratio is 60/40 or 70/30 skews every dose by 20% or more.
Not accurately. A blend vial creates a single solution containing both peptides at fixed concentrations. Drawing any volume from the vial delivers both compounds in the ratio they were mixed — you can’t selectively extract one peptide without the other. To dose peptides independently, purchase separate single-compound vials and reconstitute them individually.
CJC-1295 no DAC has a half-life of approximately 30 minutes, requiring frequent dosing to maintain elevated growth hormone levels. CJC-1295 with DAC (Drug Affinity Complex) extends the half-life to 6–8 days through albumin binding, allowing once-weekly dosing. Most research blends with Ipamorelin use the no-DAC variant because both peptides then have similar pharmacokinetic profiles, making synchronous dosing practical.
Visual inspection catches gross contamination — cloudiness, particulates, or color change indicate bacterial growth or peptide aggregation. Clear solutions don’t guarantee potency, though. Peptide degradation from temperature excursions or UV exposure produces no visible change but renders the compound inactive. The only definitive test is HPLC analysis, which isn’t practical for individual vials. This is why proper storage (2–8°C, away from light) and adherence to the 28-day use window matter.
Bacteriostatic water contains 0.9% benzyl alcohol as an antimicrobial preservative, allowing multi-dose use over 28 days. Sterile water lacks preservatives — once you puncture the vial seal, bacterial contamination risk increases with every subsequent draw. Use sterile water only for single-dose reconstitution where the entire vial is used immediately. For peptide blends intended for daily dosing over weeks, bacteriostatic water is the correct choice.
Yes — recalculate syringe units based on your new target dose using the same concentration. If you’re at 2,500mcg/mL (from 2mL reconstitution of a 5mg + 5mg vial) and want to increase from 100mcg to 150mcg per peptide, the new dose is 6 units instead of 4. Each 1-unit change represents a 25mcg dose shift at this concentration, allowing fine-tuning without wasting partially-used vials.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now